| 2025 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | ||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 44,6 M € | -10.7% | 49,9 M € | +18.1% | 42,3 M € | -6.7% | 45,3 M € | -1.3% | 45,9 M € | +11.9% | 41,0 M € | -1.3% | 41,5 M € | -28.2% | 57,8 M € | -72.8% | 212,8 M € | +48.1% | 143,7 M € | -47.3% | 272,8 M € | -0.0% | 272,9 M € | +8.4% | 251,7 M € | -0.7% | 253,4 M € | +5.8% | 239,4 M € | +12.3% | 213,2 M € | +12.9% | 188,8 M € | +4.2% | 181,2 M € | -10.0% | 201,4 M € | |
| EBITDA | 2,0 M € | -66.8% | 6,0 M € | +4101.9% | -150,9 k € | -108.3% | 1,8 M € | -43.9% | 3,2 M € | +200.3% | -3,2 M € | -24.6% | -2,6 M € | +66.1% | -7,6 M € | -222.3% | 6,2 M € | +144.2% | -14,1 M € | -342.4% | 5,8 M € | -64.2% | 16,2 M € | -27.1% | 22,2 M € | -0.2% | 22,3 M € | +12.4% | 19,8 M € | +3.2% | 19,2 M € | +17.6% | 16,3 M € | +55.3% | 10,5 M € | -26.0% | 14,2 M € | |
| Operating profit | 2,2 M € | -59.0% | 5,4 M € | +1347.7% | -430,6 k € | -133.7% | 1,3 M € | -50.8% | 2,6 M € | +171.1% | -3,7 M € | -128.4% | -1,6 M € | +65.6% | -4,7 M € | -447.3% | 1,3 M € | +108.4% | -16,0 M € | -476.5% | 4,3 M € | -71.9% | 15,1 M € | -28.9% | 21,3 M € | +0.8% | 21,1 M € | +19.0% | 17,7 M € | +8.8% | 16,3 M € | +14.2% | 14,3 M € | +97.8% | 7,2 M € | -40.4% | 12,1 M € | |
| Profit/loss | 9,7 M € | +53.1% | 6,3 M € | -81.2% | 33,6 M € | +3165.5% | 1,0 M € | +100.6% | -170,2 M € | -982.5% | 19,3 M € | +179.6% | -24,2 M € | +21.8% | -31,0 M € | +81.0% | -162,8 M € | -260.6% | -45,1 M € | -75.8% | -25,7 M € | -72.1% | -14,9 M € | -450.3% | 4,3 M € | -32.8% | 6,3 M € | -34.7% | 9,7 M € | -16.5% | 11,6 M € | +77.9% | 6,5 M € | +417.9% | -2,1 M € | -185.1% | 2,4 M € | |
| Equity | 514,7 M € | +3.3% | 498,2 M € | +1.3% | 491,9 M € | +7.3% | 458,3 M € | -33.1% | 684,6 M € | -19.9% | 854,8 M € | +2.3% | 835,5 M € | +1150.4% | -79,5 M € | -63.8% | -48,6 M € | -142.5% | 114,2 M € | -28.3% | 159,4 M € | -13.9% | 185,0 M € | -7.5% | 200,0 M € | +440.5% | 37,0 M € | +0.1% | 37,0 M € | +0.1% | 37,0 M € | +1.5% | 36,4 M € | +7.1% | 34,0 M € | -5.7% | 36,0 M € | |
| Total assets | 529,1 M € | +3.7% | 510,4 M € | +1.4% | 503,3 M € | +7.1% | 469,8 M € | -32.5% | 695,7 M € | -19.7% | 866,7 M € | +2.0% | 849,9 M € | +0.3% | 847,7 M € | -3.6% | 879,3 M € | -15.8% | 1,0 Md € | -3.9% | 1,1 Md € | +3.4% | 1,0 Md € | -0.5% | 1,1 Md € | +102.3% | 521,7 M € | +37.0% | 380,7 M € | +26.6% | 300,6 M € | -4.0% | 313,1 M € | +7.7% | 290,6 M € | -2.0% | 296,7 M € | |
| Cash | 66,1 k € | +8.4% | 61,0 k € | +2018.1% | 2,9 k € | -16.5% | 3,4 k € | -61.7% | 9,0 k € | +104.7% | 4,4 k € | -93.7% | 69,8 k € | +1190.2% | 5,4 k € | -37.1% | 8,6 k € | +125.0% | 3,8 k € | -100.0% | 78,5 M € | +254.5% | 22,1 M € | -79.2% | 106,5 M € | +45.2% | 73,3 M € | +96.4% | 37,3 M € | -41.2% | 63,5 M € | +84.1% | 34,5 M € | +64.5% | 21,0 M € | -52.6% | 44,2 M € | |
| Debts | 14,4 M € | +22.6% | 11,7 M € | +11.8% | 10,5 M € | -2.7% | 10,8 M € | +6.5% | 10,1 M € | -6.6% | 10,8 M € | -21.2% | 13,8 M € | -98.5% | 926,4 M € | +0.5% | 921,8 M € | -0.8% | 929,2 M € | +0.3% | 926,0 M € | +7.1% | 864,5 M € | +1.1% | 854,9 M € | +76.5% | 484,4 M € | +41.0% | 343,6 M € | +30.4% | 263,4 M € | -4.6% | 276,2 M € | +8.0% | 255,7 M € | -1.5% | 259,7 M € | |
| Staff | 52,5 | 86,3 | 88,2 | 93,6 | 92,3 | 96 | 107,2 | 121 | 177,5 | 173,2 | 175,7 | 161,8 | 136,3 | 138,4 | 146,4 | 150,2 | 151,9 | 161 | 169 | |||||||||||||||||||
Public limited company · Gent · incorporated on 05/05/1977 · 52,5 ETP
Public limited company profitable and well capitalised. Cash position rising (+8.4%).
Solid counterparty for a standard engagement.
Perrigo Belgium is a Public limited company incorporated in 1977. Its main activity is: Wholesale of pharmaceutical goods. Its registered office is in Gent. It employs on average 52,5 ETP workers (FTE).
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette